[Phase II therapeutic trial (screening) of ifosfamide in hematosarcomas and solid tumors].
D003520:Cyclophosphamide / Q000627:therapeutic use*; D004341:Drug Evaluation; D006394:Hemangiosarcoma / Q000188:drug therapy; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects; D009369:Neoplasms / Q000188:drug therapy*
D003520:Cyclophosphamide; D007069:Ifosfamide
Essai thérapeutique phase II ("screening") de l'ifosfamide dans les hématosarcomes et les tumeurs solides